Clinical trial
A Phase I Study of AK159 in Healthy Postmenopausal Women
NCT01935479 is registered in ClinicalTrials.gov with Asahi Kasei Therapeutics Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of AK159 in Healthy Postmenopausal Women
- Lead sponsor
- Asahi Kasei Therapeutics Corporation
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2013
- Completion date
- February 28, 2014
- Enrollment
- 170 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.